Schrodinger Inc Review Data Presented From CDC7 Program At (AACR) Annual Meeting - Corporate Call Transcript
¶ -
Good morning, everyone. Welcome to today's webcast, where we will review the preclinical data from our CDC7 program that was presented on Saturday, at the virtual AACR Annual Meeting. We'll also provide an overview of 2 other internal programs MALT1 and WEE1, as well as highlight the role of our computational platform and accelerating the discovery of our novel molecules.
Please note that portions of today's discussion, including our responses to questions, may include forward-looking statements about our future expectations and plans, including the speed and capacity of our platform, the clinical potential of our internal programs, the favorable properties of the inhibitors we've identified, our clinical development plans and our operational plans and strategies. Our actual results may differ materially from what we describe today due to a number of important factors, including the considerations described in the Risk Factors section of our Form 10-K and in other filings that SchrÃ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |